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Ever since it was shown for the ﬁrst time that lactate can support neuronal function in vitro
as a sole oxidative energy substrate, investigators in the ﬁeld of neuroenergetics have
been debating the role, if any, of this glycolytic product in cerebral energy metabolism.
Our experiments employed the rat hippocampal slice preparation with electrophysiological
and biochemical methodologies.The data generated by these experiments (a) support the
hypothesis that lactate, not pyruvate, is the end-product of cerebral aerobic glycolysis; (b)
indicate that lactate plays a major and crucial role in affording neural tissue to respond
adequately to glutamate excitation and to recover unscathed post-excitation; (c) suggest
that neural tissue activation is accompanied by aerobic lactate and NADH production, the
latter being produced when the former is converted to pyruvate by mitochondrial lactate
dehydrogenase (mLDH); (d) imply that NADH can be utilized as an endogenous scavenger
of reactive oxygen species (ROS) to provide neuroprotection against ROS-induced neuronal
damage.
Keywords: lactate, glycolysis, LDH, hippocampal slice, neuronal function, reactive oxygen species, NADH,
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INTRODUCTION
Almost a quarter of century ago we demonstrated for the ﬁrst
time the ability of cerebral tissue in vitro to sustain normal neu-
ronal function by utilizing lactate aerobically as its sole energy
substrate (Schurr et al., 1988). The debate that ensued following
this discovery on whether or not lactate plays a major role in cere-
bral energy metabolism continues, although much more evidence
in favor of such a role has been accumulated over that period
(Gladden, 2004; Schurr, 2006; Pellerin et al., 2007; Mangia et al.,
2009; Zielke et al., 2009; Barros and Deitmer, 2010; Ivanov et al.,
2011; Wyss et al., 2011). It is important to realize that lactate has
never been suggested to replace glucose as the main energy sub-
strate, but rather to play an important, maybe even a crucial role,
especially in speciﬁc situations. However, for many who still hold
that lactate is simply the end-product of anaerobic glycolysis, it
is difﬁcult to visualize this monocarboxylate as a major player in
cerebral energy metabolism. Consequently, the debate over lac-
tate role in energy metabolism continues unabated for almost two
decades.
The ﬁndings of Pellerin and Magistretti (1994) and the hypoth-
esis they have offered to explain them, i.e., the astrocytic-neuronal
lactate shuttle hypothesis (ANLSH), have been supported by many
studies over the years (Hu andWilson,1997a; Schurr et al., 1997a,b,
1999a,b; Mangia et al., 2003; Kasischke et al., 2004; Schurr, 2006;
Atlante et al., 2007; Schurr and Payne, 2007; Larsen et al., 2008;
Passarella et al., 2008; Gallagher et al., 2009). Those who disagree
with the ANLSH quarrel mainly about the central role attrib-
uted to lactate in this hypothesis and the studies supporting it
(Chih et al., 2001; Chih and Roberts, 2003; Hertz, 2004; Dienel
and Hertz, 2005; Korf, 2006; Hertz et al., 2007; Gandhi et al.,
2009). While glucose is, indisputably, the only energy substrate
that can enter glycolysis, the fate of glucose in this pathway is
in dispute. Many continue to hold that aerobic glycolysis’s end-
product is pyruvate, the monocarboxylate that is the substrate for
the mitochondrial tricarboxylic acid cycle, while lactate is glycol-
ysis’s end-product only under anaerobic conditions. Accordingly,
an increase in oxygen supply should occur to allow for the increase
in energy demands upon neural activation. Hence, the detractors
of lactate’s role as an energy substrate during neural activation
claim that an increase in oxygen supply could be achieved simply
by an increase in cerebral blood circulation. Although an increase
in microcirculation at the activation region has been correlated
with a spike in oxygen consumption (Malonek andGrinvald, 1996;
Vanzetta and Grinvald, 1999) and with a similar spike in NADH
level measured in vitro (Kasischke et al., 2004), these measure-
ments did not reveal the identity of the oxidized energy substrate.
Nevertheless, the prevailing assumption of those who discount
the role of lactate is that as long as there are sufﬁcient supplies
of oxygen and glucose, glycolysis should produce enough pyru-
vate to satisfy the heightened energy demands upon activation.
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This scenario does not take into account the fact that glucose is
incapable of increasing glycolytic ﬂux and thus of up-regulating
VO2, while lactate is capable of producing a dose-dependent
increase in VO2 (Levasseur et al., 2006). The study by Hu and
Wilson (1997b) actually alludes to this very phenomenon. Thus,
we afforded it a closer reexamination in light of the discount and
criticism it received so far (Dienel and Hertz, 2005; Fillenz, 2005;
Korf, 2006). Hence, in aiming to clarify some of the contentious
issues that continue to divide investigators in the ﬁeld of cerebral
energy metabolism, we consider here several of our own studies
and postulates, including one unpublished study, along with the
study of Hu and Wilson (1997b). These considerations have led
us to contend that most of the disagreements as to lactate’s role
in cerebral energy metabolism could be easily settled if and when
lactate is “allowed” to be the only end-product of glycolysis, both
aerobic and anaerobic.
MATERIALS AND METHODS
The experimental portions of the studies already published by
us and that are part of the considerations and elaborations here-
with can be found in the respective papers. All the experiments
in those studies and in the unpublished one we are detailing here
employed the rat hippocampal slice preparation, using electro-
physiological and biochemical modalities. Therefore, the meth-
ods described below apply to the unpublished data on the role
of lactate in neuroprotection against glutamate-mediated, reac-
tive oxygen species (ROS)-induced neuronal damage, the results
of which are shown in Figures 8–10. Adult (200–350 g) male
Sprague-Dawley rats were used with diligent attention to mini-
mizing animal stress. Rats were housed in the animal facility at
the University of Louisville School of Medicine, maintained on
a 12 h light/12 h dark cycle at 22˚C and had unlimited access
to food and water. All protocols were approved by the Univer-
sity of Louisville School of Medicine Institutional Animal Care
and Use Committee. For each experiment, one rat was decapi-
tated under ether anesthesia, its brain rapidly removed and rinsed
with cold (6–8˚C) artiﬁcial cerebrospinal ﬂuid (aCSF, see com-
position below) and dissected. Isolated hippocampi were sliced
transversely at 400μm with a McIlwain tissue chopper and the
resulting slices (10–12 slices per hippocampus) were placed in
a dual linear-ﬂow incubation/recording chamber (Schurr et al.,
1985). Each of the two compartments of the chamber was sup-
plied with a humidiﬁed gas mixture (95% O2/5% CO2) through
separate ﬂow meters (2 l/min) and aCSF via a dual peristaltic
pump (1ml/min). The aCSF composition was (in mM): NaCl
124; KCl 5; NaH2PO4 3; CaCl2 2.5; MgSO4 2; NaHCO3 23; d-
glucose 10. The aCSF had a pH of 7.3–7.4 and an osmolality of
300± 5mOSM. The temperature of the incubation chamber was
held at 34± 0.3˚C. After 60min of incubation, the 10mM glucose
aCSF was replaced either with 2.5mM glucose-, 5mM Na-lactate-
, or 5mM Na-pyruvate-aCSF. A 45min period of equilibration
with the replacement medium was allowed before the begin-
ning of electrophysiological recordings of evoked (once/min)
CA1 population spike (PS, neuronal function). Each experimental
protocol lasted 60min. Glutamate (Glut; 2.5mM) and 3-methyl-
1-phenyl-2-pyrazolin-5-one (MCI-186, 33μM), a free radical
scavenger (Wu et al., 2006) were supplemented when indicated.
In other experiments, 5mM pyruvate-aCSF was replaced with
either (1mM lactate+ 4mM pyruvate)-aCSF or (0.5mM glu-
cose+ 4mM pyruvate)-aCSF.
ELECTROPHYSIOLOGICAL MEASUREMENTS
Continuous (45min) extracellular recordings of electrically
evoked PS in the stratum pyramidale of the hippocampal CA1
region were made from one slice in each compartment of the
dual chamber using borosilicate micropipettes ﬁlled with aCSF
(impedance 2–5MΩ). A two-channel preampliﬁer (×100) and
two ﬁeld-effect transistor head stages (custom-made) were used.
Bipolar stimulating electrodes were placed in the Schaffer collat-
erals (orthodromic stimulation) and stimulus pulses (0.1ms in
duration) of an amplitude twice threshold (∼10V) were applied
once/min to evoke a response, using two Grass S44 stimulators
and two SIU-V constant voltage stimulus isolation units (Grass
Technologies, West Warwick, RI, USA). The presence of neuronal
function (PS of >3mV) in each of the slices in both compart-
ments of the dual chamber was veriﬁed prior to the beginning of
the experimental protocol. The above value of the PS has been
determined as our standard, based on hundreds of experiments
over 25 years, as the minimum amplitude of a PS that can be accu-
rately measured to indicate the presence of neuronal function that
could safely be distinguished from an artifact. Nevertheless, the
majority of viable, neuronally functional, slices typically exhibited
the maximal PS amplitude in response to the chosen electrical
stimulation (8–10mV). After 45min of continuous recording in
one slice in each compartment, the rest of the slices were tested for
the presence and amplitude of their PS by stimulating the Schaffer
collaterals and recording the evoked response in the CA1 cell body
layer, a test that lasted 10–15min. Acquisition, analysis and storage
of datawas done using theCED1401mk II data acquisition system
with Spike 2 software package (Cambridge Electronic Design cor-
poration, Cambridge, UK). All chemicals were of analytical grade
(Sigma Chemical, St. Louis, MO, USA). Each experiment (condi-
tion)was repeated three times (30–36 slices). Separate experiments
(not shown here) were carried out to determine the optimal con-
centration of glucose, lactate, pyruvate, Glut, and MCI-186 used
in this study.
DETERMINATION OF LACTATE AND GLUCOSE LEVELS IN HIPPOCAMPAL
SLICES
Lactate and glucose were measured using the enzymatic kits of
Sigma Chemical Co. (St. Louise, MO, USA). Slices were taken out
of the incubation-recording chamber at the time points indicated,
rinsed in ice-cold aCSF containing no glucose and homogenized
in 0.2ml of 8% perchloric acid. The homogenate was then neu-
tralized with 0.1ml of 2M KHCO3 and centrifuged for 3min at
8000× g. The supernatant (0.1ml) was used for the analysis of
both lactate and glucose. Assays were automated on the Cobas
Fara centrifugal analyzer (Roche Diagnostic Systems, Branchburg,
NJ, USA). The lactate kit (826-UV) uses lactate dehydrogenase
to convert lactate and NAD+ to pyruvate and NADH, respec-
tively. The glucose kit uses hexokinase to convert glucose and
ATP to glucose-6-phosphate and ADP. Glucose-6-phosphate is
subsequently oxidized by glucose-6-phosphate dehydrogenase and
NAD+ to 6-phosphogluconate and NADH. In both assays,NADH
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wasmeasured ﬂuorometrically (excitation at 340 nmand emission
at 450 nm).
ROS MEASUREMENTS USING FLUORESCENT MEASUREMENTS
Reactive oxygen species generation was assessed using the
ﬂuorescent probe 2′,7′-dichlorodihydroﬂuorescein diacetate
(H2DCFDA; Invitrogen, Carlsbad, CA, USA) as described by
Liang et al. (2005) with small modiﬁcations. The non-ﬂuorescent
H2DCFDA, which crosses the cell membrane, is deacetylated
intracellularly by non-speciﬁc endogenous esterases to its mem-
brane impermeable form, dichlorodihydroﬂuorescein (H2DCF).
H2DCF, when oxidized by ROS, is converted to the ﬂuorescent
product dichloroﬂuorescein (DCF). Brieﬂy, for each experimen-
tal sample, ﬁve slices were perfused (34˚C) for 45min with aCSF
containing 20μM H2DCFDA and the selected energy substrate
(pyruvate or lactate) with or without Glut. After 45min, slices
were perfused for an additional 10min with their respective aCSF
without H2DCFDA, then rinsed in cold aCSF and homogenized
in 1ml cold 0mM glucose aCSF containing 40μl of the detergent
Non-idet-P40 (Roche Applied Science, Indianapolis, IN, USA).
Homogenates were then spun for 20min at 12,000 rpm (13.4 g)
in 4˚C. All steps and procedures of the experiments involving
H2DCFDA were performed in the dark. Excitation at 485 nm
and emission at 535 nm was read using a SpectraFluor Plus spec-
trophotometer (Tecan, San Jose, CA, USA). Fluorescent readings
from slices incubated with pyruvate (5mM) and Glut (2.5mM)
were considered to yield the maximum DCF ﬂuorescence level
(100%; control). H2DCFDA was dissolved in methanol as stock
solution. The ﬁnal concentration of methanol in the H2DCFDA-
aCSF was less than 0.2%. All samples were read for ﬂuorescence in
duplicates and each experiment was repeated at least three times.
STATISTICAL ANALYSIS
Measurements are expressed as means± SEM. For the electro-
physiological data, statistically signiﬁcant differences between
groups were determined using the Student’s paired t -test by com-
paring control slices to glutamate-treated slices within each of
the three groups supplemented either with glucose, lactate, or
pyruvate. For the ﬂuorescence measurements of ROS, data were
assessed for statistically signiﬁcant differences using paired-sample
Wilcoxon signed rank test. For both tests, a value of p≤ 0.05 was
considered to be statistically signiﬁcant.
RESULTS AND DISCUSSION
LACTATE PRODUCTION AND UTILIZATION UPON NEURONAL
ACTIVATION
Over a decade ago, we performed two sets of experimental par-
adigms in which hippocampal slices were exposed to Glut for
15min. Slices were placed in aCSF containing 4mM glucose for
the ﬁrst paradigm (A) and 10mM for the other paradigm (B).
Accordingly, slices in paradigm A were exposed to a lower Glut
concentration (5mM) than slices in paradigm B (20mM), since
the higher the glucose concentration in the aCSF, the higher Glut
concentration slices could tolerate and the higher the level of lac-
tate slices could produce during exposure to Glut (see Schurr et al.,
1999a,b). It is important to emphasize that either concentration
of Glut by far exceeds the intrinsic physiological concentrations
of this neurotransmitter, where synaptic and extrasynaptic spaces
are concerned and is thus, excitotoxic to the hippocampal slice
preparation. Consequently, the PS amplitudemeasured during the
exposure to Glut quickly falls to 0mV, only to fully recover after
30min of Glut washout under control conditions (see samples of
PS traces in Figure 1). In contrast, high frequency electrical stim-
ulation had a much less dramatic effect on the PS amplitude, as
we have shown previously (Schurr et al., 1986). In each paradigm,
the effect of blocking lactate transport with the monocarboxy-
late transporter (MCT) inhibitor α-cyano-4-hydroxycinnamate
(4-CIN, Halestrap and Denton, 1975) was assessed. The blocker
concentration was adjusted according to the concentration of glu-
cose (0.25mM4-CINwhen glucosewas supplied at 4mM,0.5mM
4-CIN when glucose was supplied at 10mM). As can be seen
from Figure 1, blockade of MCT by 4-CIN prevented the recovery
of neuronal function after exposure to Glut in both paradigms.
Although not shown in Figure 1, it is important to mention that
FIGURE 1 |The effect of 15min exposure to glutamate (Glut) on the
ability of hippocampal slices to recover their neuronal function
following a 30min Glut washout and on the content of tissue lactate
at several time points during two experimental paradigms.
(A) Perfusion of slices with 4mM glucose aCSF for 30min, followed by a
15min exposure to 5mM Glut, followed by a 30min washout with 4mM
glucose aCSF, either in the presence of 0.25mM 4-CIN (yellow symbols) or
in the absence of 4-CIN (green symbols); (B) perfusion of slices with 10mM
glucose aCSF, followed by a 15min exposure to 20mM Glut, followed by a
30min washout with 10mM glucose aCSF in the presence of 0.5mM 4-CIN
(yellow symbols) or in the absence of 4-CIN (green symbols). Also shown
are sample traces of PS recorded from one hippocampal slice before and
during exposure to 20mM Glut and after Glut washout. Each data point
was repeated three times (30–36 slices over all). Bars are means±SD;
signiﬁcantly different from control (*p<0.003; **p<0.01; ***p<0.004).
For additional methodological details see Schurr et al., 1999a,b).
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under the experimental conditions of paradigm A some dimin-
ishment in the CA1 PS amplitude occurred during the exposure
to Glut, while under the conditions of paradigm B the CA1 PS
amplitude quickly disappeared during the 15min exposure toGlut
regardless of the presence or absence of 4-CIN (see sample traces
in Figure 1, paradigm B), indicating that Glut is excitotoxic at
both concentrations. However, the relatively short time of expo-
sure to Glut (15min) did not lead to an irreversible damage, since
over 90% of the slices under control conditions in both para-
digms exhibited almost full recovery of neuronal function (green
columns on the right side of Figure 1). Nevertheless, in the pres-
ence of 4-CIN, none of the slices exhibited recovery of neuronal
function when supplied with 4mM glucose and exposed to 5mM
Glut for 15min (Paradigm A). Less than 10% of the slices showed
recovery of neuronal function when supplied with 10mM glu-
cose and exposed to 20mM Glut for 15min (paradigm B; yellow
columns on the right side of Figure 1). While the lactate content
of control slices (green-ﬁlled circles in Figure 1) did not appear
to be elevated much during Glut exposure in either paradigm, it
may reﬂect the high rate by which neurons utilized the astrocriti-
cally produced lactate (Pellerin andMagistretti, 1994) rather than a
reduction in lactate production. The signiﬁcant elevation in lactate
tissue content of slices treated with 4-CIN during Glut exposure
demonstrates that astrocytic or more likely neuronal (Galefﬁ et al.,
2007) lactate transport is blocked and thus was unavailable to neu-
rons in these slices, blockade that prevented recovery of neuronal
function at the end of the washout period under both paradigms.
Since lactate could not be utilized in the presence of 4-CIN, its
tissue content remained elevated throughout the washout period
(yellow-ﬁlled circles in Figure 1). As expected, the content of lac-
tate in slices supplied with 10mM glucose during Glut exposure
in the presence of 4-CIN was almost twice as high as the content
of slices supplied with 4mM glucose, indicating that most of the
glucose utilized during Glut exposure is converted to lactate. In
essence, the outcome depicted in Figure 1 strongly supports the
premise of the ANLSH. These experiments with Glut (see also
Schurr et al., 1999a,b) conﬁrm that activation of neural tissue
with an excitatory neurotransmitter increases glucose utilization
via aerobic glycolysis, which leads to a large elevation in lactate
production. Moreover, as indicated by the effects of 4-CIN in the
presence of Glut, lactate is the glycolytic product that becomes
the oxidative energy substrate, securing the recovery of neuronal
function post-Glut activation.
In the debate that has ensued following Pellerin and Mag-
istretti (1994) proposed ANLSH (Tsacopoulos and Magistretti,
1996; Magistretti and Pellerin, 1999; Magistretti et al., 1999; Mag-
istretti, 2000; Chih et al., 2001; Chih and Roberts, 2003; Pellerin
and Magistretti, 2003, 2004a,b; Hertz, 2004; Schurr, 2006), the
skeptics tend to reject it mainly on the premise that lactate is pos-
tulated to be a major oxidative energy substrate, not necessarily on
the proposed shuttle per se. The debate is not limited only to this
hypothesis; it is still raging about a similar hypothesis concern-
ing lactate shuttles in other tissues that preceded the one offered
by Pellerin and Magistretti (see Gladden, 2004, for review). The
objection to the idea of a major role for lactate in energy metabo-
lism beyond just being awaste product or, at best, aminor player, is
understandable. The dogma of glucose’s obligatory role in energy
metabolism in all tissues, organs, and most aerobic organisms is
an inseparable part of our understanding and acceptance of this
process as formulated during the ﬁrst half of the twentieth cen-
tury. However, a trove of experimental data have emerged over the
past quarter of a century, all pointing to a major role for lactate
in oxidative energy metabolism in brain, skeletal muscle, heart,
and probably many other mammalian tissues. These data (Brooks,
1985, 1998, 2000, 2002a,b; Schurr et al., 1988, 1997a,b, 1999a,b;
Larrabee, 1995, 1996; Hu and Wilson, 1997b; Brooks et al., 1999;
Mangia et al., 2003; Kasischke et al., 2004; Ivanov et al., 2011),
in addition to those found in several forgotten studies from the
ﬁrst half of the twentieth century (Ashford and Holmes, 1929,
1931;Holmes, 1930;Holmes andAshford, 1930; Flock et al., 1938),
prompted us to hypothesize that lactate is the end-product of both
aerobic and anaerobic glycolysis and, consequently, is the ultimate
cerebral oxidative energy substrate in the brain (Schurr, 2006) and
possibly in other organs and tissues. The experiments described in
Figure 1 contributed greatly to the formulation of this hypothesis.
REVISITING HU AND WILSON’S STUDIES OF 1997
Among the citations cited above, the one by Hu and Wilson
(1997b) carries greater importance than has been realized by
both its supporters and detractors. These authors have developed
both glucose and lactate, enzyme-based micro-sensors with rapid
response time that allowed them direct and continuous in vivo
measurements of lactate and glucose concentrations with high
temporal resolution in rat brain extracellular ﬂuid. Several authors
(Pellerin and Magistretti, 2003; Kasischke et al., 2004; Aubert et al.,
2005; Medina and Tabernero, 2005; Serres et al., 2005; Schurr,
2006) have concluded that Hu and Wilson’s ﬁndings lend support
to the notion that lactate is being utilized aerobically upon neu-
ronal activation. Others (Dienel and Hertz, 2005; Fillenz, 2005;
Korf, 2006) have concluded that Hu and Wilson’s observations do
not represent oxidative metabolism of lactate. In his commentary,
Korf (2006) states that the initial drop in the hippocampal dentate
gyrus lactate level following a single stimulation of the perforant
pathway (Hu and Wilson, 1997b) is very small in comparison with
its subsequent increase, and thus, this minor decrease cannot serve
as an argument to support aerobic metabolism of lactate. As can
be seen from Figure 2, after the ﬁrst stimulation, the dip in lactate
concentration was 7%, while glucose level dipped by 14%. Based
on Hu and Wilson’s (1997a) estimates, the lactate baseline level
before stimulation was 1.19mM and that of glucose was 2.60mM.
Hence, following the ﬁrst stimulation, the levels of lactate and
glucose fell by 0.08 and 0.36mM, respectively.
One could surmise then that upon the ﬁrst stimulus, a signiﬁ-
cant portion of the energy required for this activation is supplied
via glycolysis (the conversion of glucose to lactate) as 0.36mM
glucose were consumed, while a smaller portion of that energy is
supplied via aerobic consumption of lactate, since only 0.08mM
of the monocarboxylate were consumed. These quantities, how-
ever, could be misleading, since 0.36mM glucose produces a net
amount of 0.72mM ATP (1mol of glucose produces 2mol of
ATP glycolytically), while 0.08mM lactate produces 2.72mM ATP
[1mol of lactate produced ∼34mol of ATP via the mitochon-
drial tricarboxylic acid (TCA) cycle]. Consequently, the “small”
amount of lactate consumed upon the ﬁrst stimulation actually
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FIGURE 2 | Profiles of time course and dynamic relationships of local
extracellular lactate, glucose, and PO2 levels in the rat hippocampal
dentate gyrus during a series of 5 s electrical stimulations (arrows) of
the perforant pathway at 2min rest intervals (reproduced with
permission from Hu andWilson, 1997b; copyright 1997, Blackwell,
Oxford).The different diagonal lines show the trend in the mean analyte
concentration during the series of stimulations. During the second to the
fourth stimulations as glucose mean level gradually decreased (line a),
lactate mean level gradually increased (line a1). During the next three
stimulations the trend was inverted (lines b and b1) and during the 7th to
the 10th stimulations the trend inverted itself again (lines c and c1). The
changes in the mean concentration of glucose were always in opposite
direction to the changes in mean lactate concentration. The vertical lines
were drawn to indicate the simultaneous dip in all three analytes in
response to each of the 10 electrical stimulations. For additional details see
Hu andWilson (1997b).
produced 3.8 times more ATP than the amount produced by the
consumption of glucose upon the ﬁrst stimulation. A signiﬁcant
fact that has been ignored by the detractors of Hu and Wilson’s
studies is the sharp increase in tissue lactate level immediately
after the ﬁrst stimulation; from 1.19 (baseline level) to 1.95mM, a
rise of 0.76mM. Concomitantly, glucose level after the ﬁrst stim-
ulation decreased from 2.60 (baseline level) to 2.22mM, a drop of
0.38mM.Hence, the rise in lactate can be fully attributed to the fall
in glucose, as every mole of the sugar is converted glycolytically to
2mol of lactate. In essence, all the glucose consumed in response to
the ﬁrst stimulation was converted to lactate. This very stoichiom-
etry was seen by us (Figure 1). Aerobic conversion of glucose to
lactate rather than to pyruvate is the central theme of our hypoth-
esis (Schurr, 2006). After the second stimulation (Figure 2), the
amplitude of the dip in lactate level measured 0.22mM (from
1.87mM or 157% of the baseline level, to 1.65mM or 139% of the
baseline level), was almost threefold larger than the one that fol-
lowed the ﬁrst stimulation and with an estimated ATP production
of 7.48mM. Glucose dipped after the second stimulation from
2.34 (90% of the baseline level) to 2.13mM (82% of the baseline
level), a dip of 0.21mM, an approximately 0.15mM smaller dip
(42% smaller) than the dip observed after the ﬁrst stimulation
and with an estimated ATP production of 0.42mM. Thus, on the
second stimulation,ATP production via lactate utilization was 18-
fold greater thanATP production via glycolytic glucose utilization.
Accordingly, we calculated the size of the dip for each of the ten
stimulations applied byHu andWilson (1997b) and also estimated
FIGURE 3 |The time course of changes in the amplitude of the dip in
tissue glucose and lactate levels in the rat hippocampal dentate gyrus
after each of the 10 electrical stimulations applied to the perforant
pathway at intervals of 2min (bottom panel).The amplitude of each dip
(in mM) was calculated from the data of Hu andWilson (1997b) as
reproduced in Figure 2. The upper panel illustrates the estimated ATP
amount produced based on the size of the dip (in mM) in tissue glucose
and lactate levels as shown in the bottom panel. The estimated ATP levels
were calculated as follows: the glucose measured dip (in mM) was
multiplied by 2, which is the net formation of 2mol of ATP for each mole of
glycolytically metabolized glucose; the lactate measured dip (in mM) was
multiplied by 34, which is the net formation of 34mol of ATP for every 2mol
of lactate (formed glycolytically from 1mol of glucose) metabolized via the
mitochondrial TCA and the oxidative phosphorylation chain.
the resulted ATP production from glucose and lactate after each
of them, calculations that are summarized in Figure 3. Despite
the signiﬁcant increases in lactate “utilization” and decreases in
glucose “utilization” beginning with the second stimulation on,
Korf (2006) states that there is no less glucose metabolized after
repeated stimulation, since the concomitant early dips in glucose
remain the same, independent of the changes in lactate. This state-
ment is inaccurate and could be misleading, since it does not take
into account the simple fact that every mole of lactate oxidized
produces approximately 17 times more ATP than a mole of glu-
cose. The breakdown of 1mol of glucose glycolytically requires
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two phosphorylation steps (2mol of ATP) to produces two trioses,
each of which later produces 2mol of ATP for a net production
of 2mol of ATP for each mole of glucose that passes through gly-
colysis (Stryer, 1995; see also Figure 4). In contrast, upon entering
the mitochondrial TCA cycle and the oxidative phosphorylation
chain, the 2mol of lactate (pyruvate) created from1mol of glucose
via glycolysis, produce approximately 32–34mol of ATP (Stryer,
1995) or 16–17 times more ATP than is produced from 1mol
of glucose via glycolysis. Furthermore, over the ﬁrst four stim-
ulations glucose tissue level continued to drop as lactate tissue
level increased (Figure 2, lines a and a1), while during the next
four stimulations as lactate tissue level decreased, glucose tissue
level increased (Figure 2, lines b and b1). Hu and Wilson (1997b)
found this trend noteworthy in their original paper. Although we
have not analyzed quantitatively the oxygen proﬁle produced by
Hu and Wilson (1997b) in their Figure 2, the authors indicated
that unlike the levels of glucose, O2 levels showed essentially no
decrease. Thus,one could surmise that each oxygendip in response
to an electrical stimulation signals a concomitant O2 utilization in
the mitochondrial electron transport chain with lactate utilization
(via pyruvate) in the TCA cycle, the very lactate that is originating
glycolytically from glucose.
A study by Mangia et al. (2003), using a time-resolved proton
magnetic resonance (1H-MRS) in humans, found an approxi-
mately 40% dip in lactate tissue concentration 5 s after a 1 s visual
stimulation with a recovery back to baseline levels by 12 s. Due
to the experimental conditions adopted by Mangia et al. (2003),
any increase in lactate concentration, had it occurred, could not
be measured. Nevertheless, it is interesting that both Mangia et al.
(2003) and Fillenz (2005) interpreted the results of the MRS study
as refutation of theANLSH (Pellerin and Magistretti, 1994),which
postulates that an increased astrocytic lactate production supports
the bulk of the energy needs of Glut-activated neurons. Hence,
according to Mangia et al. (2003) and Fillenz (2005) the short-
lived dip in lactate concentration, which, in essence, signals lactate
consumption, is sufﬁcient to reject the ANLSH. Moreover, Fillenz
(2005) takes Hu and Wilson’s (1997a,b) data to demonstrate “that
glucose is the main substrate used by activated neurons.” In the
general scheme of things, it is true that glucose is used during
neural activation, but for the purpose of producing lactate, most
likely by astrocytes. Considering the lopsided difference in the
amount of ATP formed via lactate aerobic utilization compared to
that produced via glucose glycolytic utilization (see Figure 3, top
panel), it is apparent that more than 95% of the ATP produced
and consumed by the activated neural tissue is supplied by lactate
oxidation. Since the debate over the ANLSH has arguably become
the basis on which the idea of lactate as an oxidative energy sub-
strate stands or falls, some participants in this debate set aside
data that could neither directly support nor refute this hypothesis.
Thus, in their mathematical model, Aubert et al. (2005) selected
only the lactate measurements from the data of Hu and Wilson
(1997b), leaving out the measurements of glucose and oxygen that
were performed concomitantly with those of lactate. Therefore, on
the basis of ours and others analyses we believe that the studies of
Hu andWilson (1997a,b) should be reevaluated by those who have
discounted them for one reason or another. The principle thrust of
their studies is not whether they support or discredit the ANLSH,
but rather that they clearly indicate that lactate, the glycolytic prod-
uct of glucose, is the only substrate capable of answering all the
energy needs of activated neural tissue.
LACTATE, NOT PYRUVATE IS AEROBIC GLYCOLYSIS END-PRODUCT IN
THE BRAIN
Considering our own work over the past two decades and the
accumulating data from a multitude of studies, the concept of lac-
tate as an integral intermediate of normal glucose metabolism and
ATP production, i.e., aerobic glycolysis and oxidative phospho-
rylation, has become more main stream and less controversial.
Consequently, we hypothesized, as mentioned earlier, that in the
brain lactate is the principal product of both aerobic and anaerobic
glycolysis (Figure 4; Schurr, 2006).
We have tested this proposed hypothesis in a study that has pro-
vided additional evidence in its support (Schurr and Payne, 2007).
A newly discovered lactate dehydrogenase inhibitor, malonate, a
known competitive inhibitor of succinate dehydrogenase, has been
shown to inhibit the conversion of lactate to pyruvate by Saad et al.
(2006). This succinate analog is transported into neurons, astro-
cytes, and mitochondria via the succinate transporter (Aliverdieva
et al., 2006; Yodoya et al., 2006). We used malonate in a set of
experiments to test the hypothesis that lactate is the end-product
of aerobic glycolysis in cerebral tissue (Schurr and Payne, 2007). As
can be seen from Figure 5,malonate (M) drastically attenuated the
amplitude of lactate-supported neuronal function (evoked hip-
pocampal CA1 PS), as evident from the two representative traces
before (L) and after 75min exposure to the inhibitor (L+M).
Lactate-supplemented slices were susceptible to LDH inhibition
by malonate, exhibiting a time-dependent diminishment in the
PS amplitude. However,malonate was innocuous when slices were
supplemented with pyruvate (P, P+M). Thus, this LDH inhibitor
appeared to be a more efﬁcient inhibitor than any other known
one, especially of mLDH, the mitochondrial form, which converts
lactate to pyruvate. The inhibition of the mLDH by malonate
signiﬁcantly slowed down the conversion of lactate to pyruvate,
resulting in the observed suppression of neuronal function. Since
pyruvate can directly enter the mitochondrial TCA cycle, as it
is transported by the same transporter (MCT) that transports
lactate, pyruvate-supported neuronal function was unaffected by
malonate.With glucose-supplemented slices the effect of malonate
was signiﬁcantly different. Although initially malonate suppressed
the PS amplitude of both lactate-supplemented slices by 48% at
45min incubation (45′ L+M)andof glucose-supplemented slices
by 36% (45′ G+M), at 75min however, the suppression of the PS
amplitude of the lactate-supplemented slices increased to 75% (75′
L+M), while that of the glucose-supplemented slices was sub-
sided to only 14% (75′, G+M).While all LDH inhibitors, without
exception, exhibit differential inhibition toward either cLDH, the
cytosolic form of the enzyme, or mLDH, the mitochondrial form,
they do inhibit both forms if allowed long enough incubation time.
Hence, the biphasic effect of malonate on the neuronal function of
glucose-supplemented slices is predictable, since this inhibitor has
stronger inhibitory potency toward mLDH than toward cLDH.
Therefore, in the short run, malonate is expected to block mainly
the conversion of lactate to pyruvate, which indicates that lactate
is the end-product of aerobic glycolysis. If this were not the case,
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FIGURE 4 | A schematic illustration of a hypothesis first presented
elsewhere (Schurr, 2006), postulating lactate, not pyruvate, to be the
end-product of aerobic glycolysis.This hypothesis is founded on
thermodynamic and other considerations, including data from many studies
spanning almost eight decades of research by scientists in laboratories all
around the world. The illustration shows the glycolytic apparatus as an
aggregate of the glycolytic enzymes, all in close proximity to each other, as
required by such a pathway for a maximized efﬁcient output, with the entry of
glucose into this pathway on the upper left side and an exit of lactate from the
pathway on the right side through the action of cytosolic lactate
dehydrogenase (cLDH). Lactate is shuttled via an intracellular shuttle to the
mitochondrial membrane, where it is converted back into pyruvate via
mitochondrial lactate dehydrogenase (mLDH) and into the tricarboxylic acid
(TCA) cycle.
inhibition of cLDH by malonate should have no effect on glucose-
supplemented slices, since according to the classic understanding
of aerobic glycolysis, inhibition of cLDH should have no effect
on the main aerobic glycolytic product, pyruvate, and its entry
into the mitochondrial TCA cycle. Hence, the PS amplitude of
glucose-supplemented slices should not at all be affected by mal-
onate. The fact that malonate initially inhibited neuronal function
of glucose-supplemented slices clearly indicates that glucose must
ﬁrst be glycolytically converted to lactate, a product that must then
be converted by mLDH to pyruvate, a LDH form more sensitive to
malonate than the cLDH form. Over a longer period of time the
degree of inhibition of the cLDH form became more pronounced,
such that it blocked glycolysis from continuing beyond the forma-
tion of pyruvate, practically preventing lactate production. At this
point in time (75′, G+M), the accumulated glycolytic pyruvate
became the main product available for mitochondrial use, which
resulted in the observed recovery frommalonate-induced suppres-
sion of glucose-supplemented neuronal function. The somewhat
stronger inhibition of neuronal function by malonate (48%) in
lactate-supported slices at 45min (45′ L+M) than that observed
in glucose-supplemented slices (36%) also indicates that already
at this point in time, there was some inhibition of cLDH and
thus accumulation of pyruvate, allowing glucose-supplemented
slices to be affected less bymalonate than the lactate-supplemented
slices.
These results support the hypothesis, which postulates that lac-
tate is the end-product of cerebral aerobic glycolysis and also
conﬁrm that its aerobic utilization ﬁrst requires the conversion
of lactate to pyruvate via mLDH. We performed an additional
set of experiments (Schurr and Payne, 2007) that provided fur-
ther support for lactate’s major role in cerebral energy metab-
olism (Figure 6). In that set we combined Glut and malonate
to ascertain lactate’s role as a mitochondrial energy substrate
for the maintenance of neuronal function during neural acti-
vation. That malonate is detrimental to neuronal viability of
glutamate-activated, glucose-supported hippocampal slices was
apparent from the partial recovery (50%) of the energy-dependent
PS amplitude (Figure 6). This outcome indicates that lactate,
www.frontiersin.org January 2012 | Volume 2 | Article 96 | 7
Schurr and Gozal Lactate, neuronal activation, and neuroprotection
FIGURE 5 |The effect of the LDH inhibitor, malonate (M, 10mM) on
evoked CA1 population spike amplitude (neuronal function) of rat
hippocampal slices maintained is aCSF containing either lactate (L,
5mM), pyruvate (P, 5mM), or glucose (G, 2.5mM). Malonate
progressively inhibited lactate-supported neuronal function over time and
was innocuous against pyruvate-supported neuronal function. Malonate
initially inhibited glucose-supported neuronal function, inhibition that was
later mostly relieved. Each data point was repeated three times (30–36
slices over all). Bars are means±SEM; *signiﬁcantly different from energy
substrate alone; **signiﬁcantly different from energy substrate or energy
substrate+malonate at 45min (p<0.0001). For additional methodological
details see Schurr and Payne (2007).
whether neuronal or astrocytic in origin, is crucial for neuronal
viability upon activation. These results conﬁrm both our previous
ﬁndings (Figure 1; Schurr et al., 1999a,b) and the outcome of Hu
and Wilson’s (1997b) experiments. Alternatively, the outcome of
our experiments could be explained by postulating an increase in
astrocytic glucose utilization and lactate production in response to
Glut uptake, whereupon lactate becomes a major neuronal energy
substrate (Pellerin and Magistretti, 1994; Schurr et al., 1999a). Any
interference with neuronal utilization of astrocytic lactate under
this scenario, i.e., LDH inhibition by malonate, would suppress
normal neuronal function. However, such suppression would be
abolished if astrocytes, although incapable of lactate production
in the presence of malonate, could produce enough pyruvate. That
product, upon Glut washout, should be able to fuel the recovery
of neuronal function, similar to the observed recovery in slices
supplied with exogenous pyruvate (Figure 6). Nevertheless, such
recovery did not occur, which indicates that astrocytic pyruvate,
if produced during exposure to Glut and malonate, was not read-
ily available to neurons, in contrast to the availability of astrocytic
lactate and neuronal pyruvate and to the ﬁndings of Yoshioka et al.
(2000).
Why was 2.5mM glucose, in contrast to 5mM pyruvate, unable
to sustain neuronal viability in slices treated with both malonate
and Glut? It is possible that not all the available glucose is con-
verted glycolytically to pyruvate under these conditions. However,
glucose-supplemented slices incubated for 20min with both Glut
and malonate should produce enough glycolytic lactate without
a signiﬁcant inhibition of glycolysis by malonate (see Figure 5).
Thus, malonate, under these conditions, appears to mainly inhibit
FIGURE 6 |The effect of 20min exposure to glutamate (Glut, 2.5mM)
on hippocampal CA1 evoked population spike (PS, neuronal function)
in the absence or presence of the LDH inhibitor, malonate (10mM)
when either glucose (2.5mM) or pyruvate (5mM) was the sole energy
substrate. Slices maintained in glucose aCSF could not recover their PS
amplitude following Glut washout in the presence of malonate as compared
to those maintained in the absence of malonate or those maintained with
pyruvate whether malonate was absent or present. Slices were exposed to
malonate throughout the experimental protocol for a total of 80min (30min
before the exposure to Glut, 20min during the exposure to Glut and 30min
during Glut washout). Each data point was repeated three times (30–36
slices). Bars are means±SEM; *signiﬁcantly different from the mean
values before exposure to either malonate or Glut (p<0.01). For additional
methodological details see Schurr and Payne (2007).
lactate conversion to pyruvate by mLDH, which would prevent
the full recovery of neuronal function (Figure 6). One should also
consider the fact that in order to meet the activated neural tissue
increased energy needs, glucose cannot attenuate the rate of mito-
chondrial respiration through a concomitant increase in the gly-
colytic ﬂux. In contrast, lactate, andmost likely pyruvate, can easily
do so, since they both enter the mitochondria directly. Levasseur
et al. (2006) have demonstrated that glucose sustained mitochon-
drial respiration at low, “ﬁxed” rate, since, despite increasing the
glucose concentration nearly 100-fold, oxygen consumption was
not up-regulated. However, an increase in lactate concentration
did elevatemitochondrial oxygen consumption,plausibly allowing
mitochondria to meet heightened energy demands. Consequently,
in our experiments, glucose-supplemented and oxygenated hip-
pocampal slices were incapable of increasing their mitochondrial
respiration rate in response to activation by Glut, since they were
unable to up-regulate their glycolytic ﬂux, while at the same time
could not utilize lactate directly because of the presence of mal-
onate. Interestingly, the ﬁndings of Hu and Wilson (1997b) also
agree with the interpretation of Levasseur et al. (2006). More
recently, Ivanov et al. (2011) have demonstrated that lactate can
cover the energy needs of activated neonatal hippocampal slices
and that lactate utilization augmented oxidative phosphorylation.
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Normally, both neuronal and astrocytic lactate produced from
glucose would overcome this limitation (see Figure 5, control
glucose, 2.5mM), but in the presence of malonate this avenue
is unavailable (Figure 5, malonate, glucose, 2.5mM). Obviously,
exogenous lactate would be useless in the presence of malonate,
which is the reason no results with lactate-supported slices are
shown. Nonetheless, results obtained when slices supplemented
with 2.5mM glucose were also supplemented with malonate and
exposed to Glut (for 20min; Figure 6) suggest an augmented
shortfall in lactate (or pyruvate) supply under these conditions.
This outcome emphasizes the importance of lactate both at rest
and during neural activation, an outcome that cannot be explained
by the classic depiction of aerobic glycolysis, where pyruvate is
positioned as the glycolytic end-product. Using electrical stimula-
tion of several durations instead of Glut application to hippocam-
pal slices, Brennan et al. (2006) have reached a similar conclusion
to ours as to the role of mitochondrial energy metabolism, not gly-
colysis, in supporting the need for the increase in energy supplies.
Kann et al. (2011) have recently demonstrated that the induc-
tion of gamma oscillations by acetylcholine in hippocampal slices
are especially energy demanding and require both high complex
I expression and strong functional performance of mitochondria.
These authors found that the gamma oscillation power, oxygen
consumption, and Complex I expression are higher in the hip-
pocampal subﬁeld CA3 than in subﬁelds CA1 and dentate gyrus
and that they utilizemitochondrial oxidative capacity near itsmax-
imum limit. These studies along with other cited above and the
results of our experiments with the LDH inhibitor, malonate, as
summarized in Figure 7, strongly support our hypothesis (Schurr,
2006).
AEROBIC LACTATE UTILIZATION PROVIDES NEUROPROTECTION
AGAINST GLUTAMATE-MEDIATED, ROS-INDUCED DAMAGE
The ANLSH, as proposed by Pellerin and Magistretti (1994), pos-
tulates that Glut plays a central role in the coupling between neu-
ronal activity and energy metabolism. Accordingly, Glut, released
during synaptic activity, is taken up by astrocytes via speciﬁc Glut
transporters. This transport, which is sodium-dependent, triggers
astrocytic aerobic glycolysis and lactate production. The ANLSH
further postulates that the astrocytic lactate thus produced is
FIGURE 7 |Two views of aerobic glycolysis.The classic view depicts
pyruvate as the glycolytic pathway’s end-product (green arrows, left panel)
and thus as the pathway that should not be affected by an LDH inhibitor such
as malonate in supplying pyruvate to mitochondria. The results shown in
Figures 5 and 6 cannot be explained by this view. The alternative view of the
aerobic glycolytic pathway postulates lactate to be its end-product (green
arrows, right panel, Schurr, 2006). Since glycolytically produced lactate must
be converted to pyruvate to allow the latter to enter theTCA cycle, this
alternative view explains the ability of malonate to interfere with
glucose-supported neuronal function as shown in Figure 5 (right side
histograms). However, over time, malonate’s weaker inhibiting activity of the
reaction converting pyruvate to lactate shifts the glycolytic conversion of
glucose from lactate to pyruvate until the latter becomes the main glycolytic
end-product and the mitochondrial substrate (broken arrow, right panel),
relieving the suppression of neuronal function observed earlier when glucose
is the energy substrate (Figure 5).
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transported via speciﬁcmonocarboxylate transporters from astro-
cytes to neurons, where it is utilized as an oxidative mitochondrial
energy substrate (Pellerin et al., 1998; Magistretti and Pellerin,
1999). Nevertheless, Yoshioka et al. (2000), using 31P-NMR and
electrophysiology of granule cells in rat hippocampal slices, have
concluded that, upon high K+ stimulation, the astrocytic main
product is pyruvate, not lactate, and the former, not the latter is
the neuronal substrate shuttled from astrocytes to neurons. Our
results, as described in the previous section refute Yoshioka et al.
(2000) conclusion.
Several cellular mechanisms have been suggested over the years
to explain the excitotoxicity of Glut. It is now believed that cal-
ciumuptake andoverload via various glutamate receptor subtypes,
a common thread of several neurodegenerative diseases where
mitochondrial dysfunction and cellular apoptosis occur, leads to
an oxidative stress due to elevated mitochondrial production of
ROS (Krieger and Duchen, 2002; Rego and Oliveira, 2003; Emerit
et al., 2004; Rosenstock et al., 2004; Lin and Beal, 2005). Acute and
severe hypoxia in ischemic disease induce the release of Glut via
several mechanisms and down regulate Glut transporters expres-
sion, resulting in elevated extracellular Glut (Rossi et al., 2000;
Aliprandi et al., 2005; Dallas et al., 2007; Kiewert et al., 2010). The
role of excitotoxicity in the pathogenesis of ischemic brain disease
has been widely reported (Dirnagl et al., 1999; Kiewert et al., 2010)
and elevated Glut levels have been found in plasma and in CSF of
stroke patients (Aliprandi et al., 2005). The details of glial Glut
sequestration have been extensively studied: GLT1 and GLAST are
sodium-dependent Glut transporters that couple inward trans-
port of one Glut molecule with inward entry of 3 Na+, and one
H+, and outward movement of one K+. The resulting intracellu-
lar Na+ elevation stimulates the Na+/K+ ATPase pump to extrude
Na+ and the resulting energy requirement leads to enhanced glu-
cose uptake (Pellerin and Magistretti, 1994). During ischemia,
the mitochondrial respiration chain is compromised, leading to
energy failure that could be aggravated by the initial increase in
Glut uptake. Ischemia-induced energy failure leading to Na+/K+
imbalance and membrane depolarization may also reverse the
transporter, carrying Glut to the extracellular space and further
contributing to excitotoxicity (Nicholls and Atwell, 1990; Grewer
et al., 2008). The hippocampal slice preparation has been used in
our laboratory for many years to investigate and elucidate several
cellular mechanisms of cerebral ischemia/hypoxia and excitotox-
icity as well as in developing neuroprotective modalities against
these disorders. To study the ability of each of the three energy
substrates, glucose, lactate, and pyruvate, in equicaloric concen-
trations, to sustain neuronal function in activated neural tissue,
we exposed rat hippocampal slices to a relatively low concentra-
tionof Glut (2.5mM). In addition,we aimed todeterminewhether
lactate or pyruvate is the astrocytic product shuttled to neurons
and whether or not ROS are involved in the neuronal excitotoxic-
ity of Glut. Hippocampal slices supplemented with either glucose
(2.5mM), pyruvate (5mM), or lactate (5mM) sustained their
neuronal function uninterrupted throughout the duration of the
experiment (60min). Thus, a relevantly physiological concentra-
tion of glucose (2.5mM) or an equicaloric concentration (5mM)
of either lactate or pyruvate was sufﬁcient to support hippocam-
pal neuronal function in vitro without diminution. However,
when exposed to Glut (2.5mM), pyruvate-supplemented slices
(Figures 8 and 9) could not sustain their neuronal function, as
was evidenced by the diminution in the PS amplitude. In contrast,
neuronal function was diminished only slightly when glucose- or
lactate-supplemented sliceswere exposed toGlut. Replacing a frac-
tion of pyruvate (1/5) with lactate (1mM) or glucose (0.5mM)
or adding the membrane-permeable ROS scavenger (MCI-186,
FIGURE 8 |The time-dependent effect of Glut (2.5mM) on the
amplitude of electrically evoked CA1 population spike (PS, neuronal
function) in rat hippocampal slices perfused with either 5mM
pyruvate (Pyr), 5mM lactate (Lac), a mixture of pyruvate (4mM) with
lactate (1mM), or MCI-186 (33μM, MCI). Pyruvate alone could not
support neuronal function in the presence of glutamate, but mixing this
monocarboxylate with a low concentration of either lactate, glucose, or
MCI-186 overcame this inability. Each point is the mean amplitude value
recorded from three separate hippocampal slices prepared from three
different rat brains. Bars are SE of the mean. *Signiﬁcantly different from
the PS amplitude in slices perfused with pyruvate in the absence of
glutamate (p<0.02).
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FIGURE 9 |The mean, electrically evoked, population spike (PS,
neuronal function) amplitude in rat hippocampal slices perfused for at
least 45min with aCSF containing either 5mM pyruvate (Pyr), 5mM
lactate (Lac), 2.5mM glucose, 4mM Pyr+1mM Lac, 4mM
Pyr+0.5mM glucose, or 5mM Pyr+33μM MCI-186 (MCI) in the
absence or presence of 2.5mM Glut. Pyruvate alone could not sustain
neuronal function in the presence of Glut. Pyruvate inability to sustain
normal neuronal function during exposure to Glut appears to be in contrast
to the results shown in Figure 6. However, the difference stems from the
fact that in this set of experiments slices were exposed to Glut for 45min,
while in the experiments described in Figure 6 they were exposed to Glut
for only 20min. All other treatments overcame the excitotoxicity of Glut.
Each column is the mean PS amplitude recorded from at least 23 slices
prepared from at least three different rat brains. Bars are SE of the mean.
*Signiﬁcantly different from the PS amplitude in control slices not exposed
to Glut (p<0.004); **signiﬁcantly different from the PS amplitude in control
slices not exposed to Glut (p<0.00006).
33μM; Wu et al., 2006) to pyruvate-supplemented slices during
exposure to Glut, allowed the sustenance of neuronal function
without any signiﬁcantGlut-induced diminution in PS amplitude.
To verify that the formation of ROS contributes to the effect of
Glut, ROS levels in hippocampal slices were measured using the
ﬂuorescent probe DCFH2-DA, which is deacetylated in cells by
non-speciﬁc endogenous esterases and oxidized by intracellular
oxidant species to form the ﬂuorescent DCF. The results shown in
Figure 10 are expressed as percent of maximum ROS production
measured in slices supplemented with pyruvate (5mM) and Glut
(2.5mM). The ROS production in these “control” slices was arbi-
trarily assigned a value of 100%. In the absence of Glut the level
of ROS in pyruvate-supplemented slices was approximately 20%
of the level measured when Glut was present (p< 0.05). In con-
trast, ROS levels in lactate-supplemented slices treated with Glut
were only 25% of the levels measured in pyruvate-supplemented,
Glut-treated slices (p< 0.05). No difference in the level of ROS
was found between lactate-supplemented slices in the presence
or absence of Glut. Adding the ROS scavenger MCI-186 (33μM)
to pyruvate-supplemented, Glut-treated slices reduced the level
of ROS to less than 10% of control (p< 0.05). Replacement of
only 1/5 of the pyruvate concentration in pyruvate-supplemented,
Glut-treated slices with lactate (4mM pyruvate+ 1mM lactate)
was sufﬁcient to reduce the level of ROS to 44% of control
(p< 0.05). Thus, pyruvate when used as the sole energy substrate
was unable to rescue neuronal function in rat hippocampal slices
from Glut-induced, ROS-mediated damage, as was evidenced by
the large diminution in PS amplitude. In contrast, lactate, even at a
concentration one ﬁfth of that of pyruvate was able to preventGlut
excitotoxicity and reduce tissue ROS levels similar to the reduction
seen with the ROS scavenger, MCI-186. ROS production in neu-
rons during a toxic Glut challenge is believed to play a central role
in neuronal damage from hypoxia/ischemia and reperfusion. Glut
receptor-activated neuronal cell death is attributed to a massive
inﬂux of Ca2+ and subsequent (within minutes) mitochondrial
formation of ROS (Reynolds and Hastings, 1995; Vergun et al.,
2001). In the hippocampal slice preparation, Glut-induced excito-
toxic damage is expressed as a fall in PS amplitude, i.e., diminished
neuronal function (Schurr et al., 1999a). Pyruvate was unable to
sustain neuronal function in slices exposed to a relatively low con-
centration of Glut (2.5mM), as indicated by a greater than 50%
fall in PS amplitude (Figure 9). These results differ from the result
shown in Figure 6 only because the exposure toGlut here (45min)
was more than double the length slices in Figure 6 were exposed
to the excitotoxin (20min). This inability of pyruvate to sustain
normal neuronal function suggests that this monocarboxylate is
not the substrate shuttled from astrocytes to neurons upon exci-
tation by Glut, a ﬁnding contrasting the claim that pyruvate is the
monocarboxylate shuttled from astrocytes to neurons (Yoshioka
et al., 2000).
The ability of both lactate and glucose to sustain neuronal
function in the presence of Glut indicates that the metabolism
of these two substrates produces a by-product, which affords neu-
ronal tissue to withstand excitotoxicity. Clearly, that by-product
is not produced during pyruvate metabolism. Our results con-
cur with the ANLSH and its postulated lactate shuttle. In light of
pyruvate’s inability to sustain neuronal function in the presence
of Glut, we considered the only difference between the mitochon-
drial metabolism of pyruvate and lactate, i.e., the conversion of
the latter to pyruvate via the action of the mitochondrial lactate
dehydrogenase (mLDH). Reduced nicotinamide adenine dinu-
cleotide (NADH), produced as a by-product of lactate conversion
to pyruvate by both neurons (Schurr and Payne, 2007) and astro-
cytes, could provide the necessary reducing power to neutralize
Glut-induced ROS and prevent their detrimental effect. Actually,
Kirsch and De Groot (2001) were ﬁrst to suggest such a role for
NADH. We could not test this postulate by simply adding exoge-
nous NADH to slices, since NADH is membrane impermeable.
Nonetheless, we employed two alternative approaches to address
this question. In one we replaced a small fraction of the sup-
plied pyruvate with lactate (1mM) or glucose (0.5mM), fractions
that by themselves could not sustain neuronal function (Schurr
et al., 1988) and then exposed pyruvate-supplemented slices to
Glut. In the second we treated pyruvate-supplemented slices with
the membrane-permeable ROS scavenger, MCI-186 (33 μM, as
determined by dose response experiments, not shown), during
the exposure to Glut (Figures 8 and 9). When lactate (1mM) or
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glucose (0.5mM) was mixed with pyruvate (4mM) in the aCSF,
the excitotoxicity of Glu was completely abolished, since neuronal
function under these conditions remained unaffected. Adding
MCI-186 (33μM) to pyruvate-supplemented, Glut-treated slices
also prevented the Glut-induced excitotoxic damage. We deem
both approaches supportive of the ANLSH original postulate,
according to which lactate is the astrocytic product shuttled to
and utilized by neurons during activation by Glut, as lactate, not
pyruvate, metabolism yields NADH that can neutralize ROS and
abolish their toxicity.
To ascertain that increased ROS formation is correlated with
the degree of neuronal damage measured by electrophysiological
means, we employed the ﬂuorescent probe H2DCFDA to quan-
titatively measure ROS levels in hippocampal slices under several
of the conditions used in the electrophysiological portion of the
study. Such correlation, if exists,would support the central premise
of this investigation, i.e., that lactate aerobic conversion topyruvate
and the accompanied production of the reducing agent NADH
could be responsible for the neutralization of ROS. Our ﬁnd-
ings (Figure 10) demonstrate that pyruvate-supplemented slices
treated with Glut contained ROS levels signiﬁcantly higher than
any other treatment combination tested. In the absence of Glut,
ROS levels in pyruvate-supplemented slices were only 20% of the
levels measured when Glut was present. Lactate-supported, Glut-
treated slices produced signiﬁcantly less ROS (25%) than their
pyruvate-supported, Glut-treated counterparts, indicating that a
by-product of lactate metabolism is capable of neutralizing ROS,
even when the lactate concentration was as low as 1mM, although
not as efﬁcient as the ROS scavenger,MCI-186.When interpreting
these ﬁndings, it is important to consider that ROS were measured
in whole slices, measurements that may have included regions
where (astrocytic) lactate was not utilized during Glut excitation,
but where ROS were still being produced. In contrast, the elec-
trophysiological assessment of neuronal function was limited to
the CA1 region of the hippocampal slice. Several studies have
shown a correlation between ROS production in in vitro models
of epilepsy and the ability of ROS scavengers to reduce or pre-
vent ROS-induced neurodegeneration (Frantseva et al., 2000) and
the possible role NADH [NAD(P)H] plays in neuronal survival
during neurodegenerative disease and status epilepticus (Kirsch
and De Groot, 2001; Heinemann et al., 2002; Kovács et al., 2002).
Interestingly, Herrero-Mendez et al. (2009) have shown that neu-
rons, unlike astrocytes, have low levels of the enzyme Pfkfb3 (6-
phosphfructo-2-kinase/fructose-2,6-bisphosphatase-3), responsi-
ble for generating fructose-2,6-bisphosphate, the glycolytic prod-
uct that activates the enzyme 6-phophofructo-1-kinase, the regu-
lator of the glycolytic ﬂux. These investigators have demonstrated
that in neurons Pfkfb3 is continuously being degraded by E3 ubiq-
uitin ligase, disabling any signiﬁcant up-regulation of neuronal
glycolysis. In astrocytes, the low activity of the degrading enzyme
results in higher levels of Pfkfb3 that enable up-regulation of
the glycolytic ﬂux. Herrero-Mendez et al. (2009) also suggested
that the low Pfkfb3 levels in neurons allow them to utilize most
of their glucose via the pentose phosphate pathway, a pathway
known to regenerate reduced glutathione through the oxidation
of NADPH(H+), and thus, supply the necessary neuroprotective
ROS scavenger. This neuropotective mechanism could play a role
FIGURE 10 |The level of reactive oxygen species (ROS) as measured
using the fluorescence of dichlorofluorescein (DCF) extracted from
slices perfused with aCSF containing glutamate (2.5mM) and either
pyruvate (5mM), lactate (5mM), the combination of [pyruvate
(4mM)+ lactate (1mM)], or the combination of [pyruvate
(5mM)+MCI-186 (33μM)] (see details in Materials and Methods). Also
shown is a set of experiments in which Glut was omitted from the aCSF of
pyruvate-supplemented slices. Glut-treated, lactate-, or
MCI-186-supplemented slices exhibited signiﬁcantly lower levels of ROS
than pyruvate-supplemented, Glut-treated slices. Each sample for
measurement of ﬂuorescence used ﬁve slices and was prepared in
duplicates. Measurements were repeated at least three times. Bars are SE
of the mean. *Signiﬁcantly different from pyruvate+Glut (p<0.05).
in our own experimental paradigm and that of Hu and Wilson
(1997b). This mechanism could also work in parallel with the
neuroprotective action of NADH produced during the conversion
of lactate to pyruvate by mLDH. It is possible that the mitochon-
drial NADH thus formed is also being used to generate reduced
glutathione as the eventual ROS scavenger.
Taking together, the results of the electrophysiological mea-
surements and those of the direct ROS formation measurements
in hippocampal slices under the various treatment combinations,
suggest that ROS, at least in part, are responsible for Glut excito-
toxicity and neuronal damage when energy substrate availability
is restricted and that pyruvate supplementation cannot overcome
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FIGURE 11 | A simplified schematic representation of the
astrocytic-neuronal lactate shuttle hypothesis (ANLSH, Pellerin
and Magistretti, 1994) combined with our own hypothesis that
postulates lactate as the end-product of aerobic glycolysis
(Figures 4 and 7). In addition, the left panel illustrate the ability of
NADH, formed during lactate conversion to pyruvate in the neuronal
mitochondrial membrane, to neutralize Glut-induced ROS-produced
damage.
such restriction. Additionally, the results corroborate the premise
of the ANLSH, according to which lactate, the astrocytic by-
product of Glut uptake, is shuttled to neurons where it is utilized
by mitochondria as an energy substrate. We have already provided
evidence in support of aerobic neuronal production and utiliza-
tion of lactate that necessitate an accompanied NADH production
(Figures 4 and 7; Schurr, 2006; Schurr and Payne, 2007). These
results provide additional support to our previous ﬁndings and
indicate that the reducing agent,NADH, is a potential endogenous
ROS scavenger that could protect neurons fromGlut excitotoxicity
(Figure 11).
CONCLUSION
Herewe accounted for several of our studies of the last decade or so
and revisited the studies of Hu and Wilson (1997a,b), proposing
that their outcomes are best explained via the ANLSH (Pellerin
and Magistretti, 1994). Furthermore, these experimental investi-
gations, alongwithmany of the cited studies by other investigators,
strongly support our own hypothesis (Schurr, 2006) according to
which lactate is the real glycolytic end-product both aerobically
and anaerobically. Aside from the theoretical and thermodynamic
considerations in support of this hypothesis (Schurr, 2006), the
experimental results presented here provide scientiﬁc evidence in
its support. Last, but not least, the postulate that lactate is the
end-product of aerobic glycolysis means that this monocarboxy-
late must be converted to pyruvate by the mitochondrial LDH
(mLDH) to be useful as an energy substrate. This conversion is
coupled to a formation of the reducing cofactor, NADH, which
we have shown here to act as a neutralizing agent of ROS, thus
providing neuroprotection against Glut excitotoxicity.
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